<DOC>
	<DOCNO>NCT01537614</DOCNO>
	<brief_summary>Pharmacokinetics colimycin assess 12 hour administration 2M UI colimycin either aerosol IV injection , administration separate 5 10 day interval</brief_summary>
	<brief_title>Pharmacokinetic Study Aerosolized Colimycin Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Males female , adult . Suffering stable cystic fibrosis Colonized P. aeruginosa Having give informed consent . Able follow protocol Having social insurance Renal insufficiency Allergy colistin polymixins Myasthenia Recent severe hemoptysis Liver cirrhosis hepatic insufficiency Hypoalbuminemia Colonization Burkholderia cepaea Stenotrophomonas maltophilin Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>